Disease/Infection News

RSS

Scientists analyze the impact of two strategies in stopping COVID-19 pandemic

How can we best organise on-site workplace and school attendance periods and remote work to slow the circulation of Sars-CoV-2? Is it better to separate classes? Bring your whole team in at the same time? Set this up on daily or weekly schedules?

28 Aug 2021

Northwestern researchers continue investigation on all aspects of COVID-19 pandemic

Northwestern Medicine scientists continue to investigate all aspects of the COVID-19 pandemic: from molecular mechanisms of infection, to child hospitalization and single-dose vaccine response.

28 Aug 2021

NIH begins clinical trial to assess extra COVID-19 vaccine dose in people with autoimmune disease

The National Institutes of Health has begun a clinical trial to assess the antibody response to an extra dose of an authorized or approved COVID-19 vaccine in people with autoimmune disease who did not respond to an original COVID-19 vaccine regimen.

27 Aug 2021

Additional COVID-19 support deployed to the South West of England

From Friday 27 August additional support will be deployed to some local authorities in the South West of England.

27 Aug 2021

SARS-CoV-2 destabilizes host RNA to improve fitness

In a study recently published in the journal Nature Communications, scientists have mapped the interactions between SARS-CoV-2 RNA and host RNA. They have observed that the virus heavily methylates its genome using the methylation machinery of the host RNA, leading to an improvement in viral fitness.

27 Aug 2021

Recognizing viral genomes in quick, ‘CRISP’ ways

Researchers from China recently reviewed the latest advancements, applications, and prospects of virus detection using CRISPR-Cas systems.

27 Aug 2021

MS patients on anti-CD20 therapy have robust T cell responses to SARS-CoV-2 vaccination

Scientists have observed that MS patients exhibit a robust T cell response despite a reduced humoral response to COVID-19 vaccines. Read more here.

27 Aug 2021

The negative impact of the COVID-19 pandemic on adult mental health in the UK

A review of the literature on the impact of COVID-19 on adult mental health in the UK has revealed a decline in mental health. Read more here.

27 Aug 2021

ACTG announces positive data for monoclonal antibody combination therapy from the ACTIV-2 study

The AIDS Clinical Trials Group, the largest global HIV research network, which has expanded its focus to include evaluating outpatient treatment for COVID-19, today announced positive data for the monoclonal antibody combination therapy BRII-196/BRII-198 from the ACTIV-2 study of Outpatient Monoclonal Antibodies and Other Therapies.

27 Aug 2021

Study: One half of hospitalized COVID-19 patients experience persistent symptoms after one year

Most symptoms of COVID-19 in hospitalized patients are resolved within 12 months, however, around one half still experience at least one persistent symptom, a study of 1,276 patients from Wuhan, China, published in The Lancet, has found.

27 Aug 2021

Study examines safety of COVID-19 vaccine in a nationwide mass-vaccination setting

The Clalit Research Institute, in collaboration with researchers from Harvard University, analyzed one of the world's largest integrated health record databases to examine the safety of the Pfizer/BioNTech BNT162B2 vaccine against COVID-19.

27 Aug 2021

Post-traumatic stress symptoms in COVID-19 survivors linked with changes to the brain's connectivity

COVID-19 survivors report significantly higher symptoms of post-traumatic stress, and these symptoms are associated with changes to the brain's connectivity, according to a study coauthored by Vince Calhoun, Distinguished Professor of Psychology at Georgia State University and director of the Center for Translational Research in Neuroimaging and Data Science (TReNDS).

27 Aug 2021

COVID-19 vaccine potency has diminished in recent months, but still helps in saving lives

COVID-19 vaccines remain effective, but their potency has diminished in recent months, according to a nationwide study at eight sites, including Salt Lake City, Utah.

27 Aug 2021

SUSU scientists conduct CFD study to monitor the spread of respiratory viruses in enclosed areas

Scientists from the South Ural State University have conducted a CFD Study for monitoring the spread of respiratory viruses in closed spaces.

27 Aug 2021

Certain high priority groups more likely to stop taking HIV prevention treatment, study finds

A large, detailed look at patients taking HIV-prevention drug therapy finds strong adherence soon after patients get the prescription, but less consistent use thereafter, particularly among groups considered high priority for receiving the medication.

27 Aug 2021

Study: 31% of Americans had been infected with SARS-CoV-2 by the end of 2020

A new study published in the journal Nature estimates that 103 million Americans, or 31 percent of the U.S. population, had been infected with SARS-CoV-2 by the end of 2020.

27 Aug 2021

Pediatric cancer patients fare worse with COVID-19 than children without cancer

Research from a large international effort shows that 20% of children with cancer who are infected with SARS-CoV-2 develop severe infections.

27 Aug 2021

COVID-19 pandemic illuminates the importance of airborne transmission of respiratory viruses

SARS-CoV-2, the virus behind today's global coronavirus pandemic, spreads primarily by inhalation of virus-laden aerosols at both short and long ranges - and a comprehensive new assessment of respiratory viruses finds that many others probably do as well.

27 Aug 2021

Improved understanding of aerosol transmission could help control airborne respiratory viruses

The COVID-19 pandemic has revealed critical knowledge gaps and assumptions concerning how respiratory viruses spread between hosts.

27 Aug 2021

New blood test could save thousands of lives by predicting sepsis before symptoms appear

Clinicians at Portsmouth's Queen Alexandra Hospital are leading medical trials of a blood test that could help to save thousands of UK lives a year by predicting sepsis days before patients show any symptoms.

26 Aug 2021

Disease/Infection News

Scientists analyze the impact of two strategies in stopping COVID-19 pandemic

Northwestern researchers continue investigation on all aspects of COVID-19 pandemic

NIH begins clinical trial to assess extra COVID-19 vaccine dose in people with autoimmune disease

Additional COVID-19 support deployed to the South West of England

SARS-CoV-2 destabilizes host RNA to improve fitness

Recognizing viral genomes in quick, ‘CRISP’ ways

MS patients on anti-CD20 therapy have robust T cell responses to SARS-CoV-2 vaccination

The negative impact of the COVID-19 pandemic on adult mental health in the UK

ACTG announces positive data for monoclonal antibody combination therapy from the ACTIV-2 study

Study: One half of hospitalized COVID-19 patients experience persistent symptoms after one year

Study examines safety of COVID-19 vaccine in a nationwide mass-vaccination setting

Post-traumatic stress symptoms in COVID-19 survivors linked with changes to the brain's connectivity

COVID-19 vaccine potency has diminished in recent months, but still helps in saving lives

SUSU scientists conduct CFD study to monitor the spread of respiratory viruses in enclosed areas

Certain high priority groups more likely to stop taking HIV prevention treatment, study finds

Study: 31% of Americans had been infected with SARS-CoV-2 by the end of 2020

Pediatric cancer patients fare worse with COVID-19 than children without cancer

COVID-19 pandemic illuminates the importance of airborne transmission of respiratory viruses

Improved understanding of aerosol transmission could help control airborne respiratory viruses

New blood test could save thousands of lives by predicting sepsis before symptoms appear

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News